Dragon Boats: A Long History of Connecting Cultures

CSOFT’s 15th Annual Summit officially takes off on June 6th. This is our second summit at our Boston office – we tested the waters in the Fall of 2018, and this time we’re really pushing the boat out. Twice, in fact.

CSOFT’s 15th Annual Summit: Dragons, Tea, and Boats, Oh My!

Our 15th Annual Summit: Global Leaders Networking event will focus on a variety of life science industry topics. Leading executives & experts from sectors such as MedTech, pharma, and diagnostics will be hosting afternoon sessions at the Boston Public Library’s ornate Courtyard Tea Room, sharing their expertise on how to expand life science products and services internationally.

E-Learning and m-Learning Translations In The Technology Age

With the increased access to technology and the availability of resources, e-learning has become available internationally and is only rising. Platforms can advance their presence in new markets through translations and localization.

Telling an Obese Patient to Lose Weight Has No Effect on Weight Loss

A recent study from Duke University shows that a generic message from a doctor telling the patient to lose weight does not effect the weight loss of the patient.

Advancing The Treatment of Treatment-Resistant Depression

The FDA approved Spravato (esketamine) on March 5, 2019, as a treatment for Treatment-Resistant Depression (TRD).

Rare Disease Day 2019

With over 350 million patients currently diagnosed with a rare disease worldwide, what makes a rare disease ‘rare’? With the growing need for medical translations in research and patents, CSOFT bridges the gap of global healthcare.

Unique Challenges Translating to South East Asian Languages

Languages of South East Asia and the Middle East in particular have a reputation for being significantly more difficult to translate due to substantial differences from other languages in terms of text, vocabulary and grammar.

FDA Approves First Treatment of the Rare Disease aTTP

The FDA has approved the first treatment for the rare disease acquired Thrombotic Thrombocytopenic Purpura or aTTP for short. This rare disease occurs in less than .001% of the population and before had no cure.

Spring Festival Message from Shunee Yee: Sharing food, enjoying company

No matter what country you’re from, language you speak, or religion you believe in, enjoying delicious food together is an unchanging nature of mankind – allowing people to connect and appreciate the love of life by sharing stories over a good meal.

FDA Approves The First Generic Inhaler of Advair Diskus

On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.

Challenges in Translating an App UI

Many companies never expect to translate their apps, so they often are unprepared to deal with the translation process, resulting in funny or strange translations.

The Pharmaceutical Boom in South Korea

South Korea’s economy is one of the fastest growing in the world. Pharmaceutical research in 2018 alone tripled in production compared to 2017.